^
BRAF V600E
Prolymphocytic Leukemia
vemurafenib
Sensitive
:
C1
NOTCH1 mutation
Prolymphocytic Leukemia
ibrutinib
Resistant
:
C3
JAK3 mutation
Prolymphocytic Leukemia
venetoclax + ruxolitinib
Sensitive
:
C3
CDKN2A deletion
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
STAT5B N642H
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
TCL1A rearrangement
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
RAD50 Y625
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
ATM D2721N
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
PAK4 deletion
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
BRAF V600E
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
BRAF V600E
Prolymphocytic Leukemia
venetoclax
Resistant
:
C4
BRAF V600E
Prolymphocytic Leukemia
dasatinib
Resistant
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our